Adam Pascale, CFO at HEMISPHERX BIOPHARMA INC (HEB), bought 15,873 shares at $0.63 ($10K) on 2017-05-02, disclosed to the SEC on 2017-05-02.
Open-market purchase of $10k HEB by CFO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| Filing → |